Tag: cancer
-
Sensor-Pill System Designed for Cancer Drugs
A system combining a tiny sensor with oral chemotherapy drugs aims to provide physicians with closer monitoring of cancer patients’ treatments and conditions.
-
Cancer-Fighting Protein Designed to Cut Adverse Effects
A computational biology lab designed a synthetic protein that works like natural cancer-fighting proteins, but in lab mice kills cancer cells with few adverse effects.
-
Start-up Funds Univ. Medical Cannabis Research
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London.
-
Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.
-
Trial Testing Breath Detection for Cancer
A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer.
-
Nanoscale Bacteria Particles Deliver Cancer Drugs
An engineering lab developed techniques for delivering cancer drugs into tumors in lab cultures and mice with nanoscale polymer particles, aided by a strain of salmonella bacteria.
-
Post-Surgical Opioid Prescriptions Safely Cut
A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills.
-
Report – 289 Cell and Gene Therapies in Development
A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration.
-
Self-Powered Sun Exposure Chip, App Developed
A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app.
-
Janssen Licensing Cancer Antibodies in $1.8B Deal
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas.